Skip to main content
NCBI home page
Immunology logoLink to Immunology
. 1980 Apr;39(4):503–509.

Immunological, structural and functional relationships between an anti-complementary protein from Crotalus atrox venom, cobra venom factor and human C3.

J O Minta, D Man
PMCID: PMC1458030  PMID: 6769786

Abstract

An anti-complementary protein which cross-reacts with antiserum to cobra venom factor (CoF) has been highly purified from Crotalus atrox venom (CAV). On an equal weight basis, the C. atrox factor (CA-F) had one-third the anti-complementary activity of CoF and similarly consumed the terminal components of complement via the alternative pathway. The subunit compositions of CoF and CAV were similar, each being composed of alpha and beta chains held together by covalent and non-covalent bonds. Agarose gel diffusion analysis using monospecific antiserum to CoF detected a reaction of partial immunological identity between CoF and CA-F and between C3 and CA-F with the CoF and C3 precipitin lines spurring over the CA-F lines. Thus CA-F probably represents a C. atrox C3 protein which is capable of activating the alternative complement pathway via the amplification loop in a manner analogous to that of C3b and CoF.

Full text

PDF
503

Images in this article

504Figure 1
on p.504
506Figure 3
on p.506
507Figure 4
on p.507

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alper C. A., Balavitch D. Cobra venom factor: evidence for its being altered cobra C3 (the third component of complement). Science. 1976 Mar 26;191(4233):1275–1276. doi: 10.1126/science.56780. [DOI] [PubMed] [Google Scholar]
  2. Ballow M., Cochrane C. G. Two anticomplementary factors in cobra venom: hemolysis of guinea pig erythrocytes by one of them. J Immunol. 1969 Nov;103(5):944–952. [PubMed] [Google Scholar]
  3. Cochrane C. G., Müller-Eberhard H. J., Aikin B. S. Depletion of plasma complement in vivo by a protein of cobra venom: its effect on various immunologic reactions. J Immunol. 1970 Jul;105(1):55–69. [PubMed] [Google Scholar]
  4. Cooper N. R. Formation and function of a complex of the C3 proactivator with a protein from cobra venom. J Exp Med. 1973 Feb 1;137(2):451–460. doi: 10.1084/jem.137.2.451. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Dodds W. J., Pickering R. J. The effect of cobra venom factor on hemostasis in guinea pigs. Blood. 1972 Sep;40(3):400–411. [PubMed] [Google Scholar]
  6. Fearon D. T., Daha M. R., Weiler J. M., Austen K. F. The natural modulation of the amplification phase of complement activation. Transplant Rev. 1976;32:12–25. doi: 10.1111/j.1600-065x.1976.tb00226.x. [DOI] [PubMed] [Google Scholar]
  7. Fong J. S., Good R. A. Prevention of the localized and generalized Shwartzman reactions by an anticomplementary agent, cobra venom factor. J Exp Med. 1971 Sep 1;134(3 Pt 1):642–655. doi: 10.1084/jem.134.3.642. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Gaither T. A., Alling D. W., Frank M. M. A new one-step method for the functional assay of the fourth component (C4) of human and guinea pig complement. J Immunol. 1974 Aug;113(2):574–583. [PubMed] [Google Scholar]
  9. HELMKAMP R. W., GOODLAND R. L., BALE W. F., SPAR I. L., MUTSCHLER L. E. High specific activity iodination of gamma-globulin with iodine-131 monochloride. Cancer Res. 1960 Nov;20:1495–1500. [PubMed] [Google Scholar]
  10. Hunsicker L. G., Ruddy S., Austen K. F. Alternate complement pathway: factors involved in cobra venom factor (CoVF) activation of the third component of complement (C3). J Immunol. 1973 Jan;110(1):128–138. [PubMed] [Google Scholar]
  11. Katz A., Minto J. O., Toole J. W., Medwidsky W. Immunopathologic study of herpes gestationis in mother and infant. Arch Dermatol. 1977 Aug;113(8):1069–1072. [PubMed] [Google Scholar]
  12. Lennon V. A., Seybold M. E., Lindstrom J. M., Cochrane C., Ulevitch R. Role of complement in the pathogenesis of experimental autoimmune myasthenia gravis. J Exp Med. 1978 Apr 1;147(4):973–983. doi: 10.1084/jem.147.4.973. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Man D. P., Minta J. O. Purification, characterization and analysis of the mechanism of action of four anti-complementary factors in Crotalus atrox venom. Immunochemistry. 1977 Jul;14(7):521–527. doi: 10.1016/0019-2791(77)90306-8. [DOI] [PubMed] [Google Scholar]
  14. Minta J. O., Man D. P., Wasi S., Painter R. H. Interaction of Crotalus atrox venom with serum complement: kinetic analysis. Immunochemistry. 1977 Jul;14(7):513–519. doi: 10.1016/0019-2791(77)90305-6. [DOI] [PubMed] [Google Scholar]
  15. Minta J. O., Man D., Movat H. Z. Kinetic studies on the fragmentation of the third component of complement (C3) by trypsin. J Immunol. 1977 Jun;118(6):2192–2198. [PubMed] [Google Scholar]
  16. Minta J. O., Ngan B. Y., Pang A. S. Purification and characterization of a single chain precursor C3-protein (pro-C3) from normal human plasma. J Immunol. 1979 Nov;123(5):2415–2420. [PubMed] [Google Scholar]
  17. Minta J. O. Purification of native properdin by reversed affinity chromatography and its activation by proteolytic enzymes. J Immunol. 1976 Aug;117(2):405–412. [PubMed] [Google Scholar]
  18. Müller-Eberhard H. J., Götze O. C3 proactivator convertase and its mode of action. J Exp Med. 1972 Apr 1;135(4):1003–1008. doi: 10.1084/jem.135.4.1003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Ngan B. Y., Gelfand E. W., Minta J. O. A simple one-step hemolytic assay for C2 with C2-deficient human serum. J Immunol. 1977 Mar;118(3):736–741. [PubMed] [Google Scholar]
  20. Pangburn M. K., Schreiber R. D., Müller-Eberhard H. J. Human complement C3b inactivator: isolation, characterization, and demonstration of an absolute requirement for the serum protein beta1H for cleavage of C3b and C4b in solution. J Exp Med. 1977 Jul 1;146(1):257–270. doi: 10.1084/jem.146.1.257. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Pepys M. B. Role of complement in the induction of immunological responses. Transplant Rev. 1976;32:93–120. doi: 10.1111/j.1600-065x.1976.tb00230.x. [DOI] [PubMed] [Google Scholar]
  22. Rudofsky U. H., Steblay R. W., Pollara B. Inhibition of experimental autoimmune renal tubulointerstitial disease in guinea pigs by depletion of complement with cobra venom factor. Clin Immunol Immunopathol. 1975 Jan;3(3):396–407. doi: 10.1016/0090-1229(75)90027-6. [DOI] [PubMed] [Google Scholar]
  23. Schwartz H. J., Naff G. B. The effect of complement depletion by cobra venom factor on delayed hypersensitivity reactions. Proc Soc Exp Biol Med. 1971 Dec;138(3):1041–1043. doi: 10.3181/00379727-138-36046. [DOI] [PubMed] [Google Scholar]
  24. Weber K., Osborn M. The reliability of molecular weight determinations by dodecyl sulfate-polyacrylamide gel electrophoresis. J Biol Chem. 1969 Aug 25;244(16):4406–4412. [PubMed] [Google Scholar]

Articles from Immunology are provided here courtesy of British Society for Immunology

RESOURCES